The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome.
Open accessAbstract
Kawasaki syndrome (KS) is an acute febrile illness of early childhood characterized by diffuse vasculitis and marked immune activation. The present study was undertaken to determine whether the acute phase of KS is associated with circulating cytotoxic antibodies directed to target antigens induced on vascular endothelium by the monokines, IL-1, or tumor necrosis factor (TNF). Sera from 20 patients with acute KS, 11 patients in the convalescent phase of KS, and 17 age-matched controls were assessed for complement-dependent cytotoxic activity against 111In-labeled human endothelial cells (HEC), dermal fibroblasts, and vascular smooth muscle cells. Sera from patients with acute KS but not the other subject groups caused significant (p less than 0.01) complement-mediated killing of IL-1- or TNF-stimulated HEC. None of the sera tested had cytotoxicity against control HEC cultures or the other target cell types, with or without IL-1 or TNF pretreatment. Expression of the IL-1- or TNF-inducible target antigens on endothelial cells was rapid and transient, peaking at 4 h and disappearing after 24 h despite continued incubation with monokine. In contrast, we have previously shown that IFN-gamma requires 72 h to render HEC susceptible to lysis with acute KS sera. Serum adsorption studies demonstrated that IL-1- and TNF-inducible endothelial target antigens are distinct from IFN-gamma-inducible antigens. These observations suggest that mediator secretion by activated monocyte/macrophages could be a predisposing factor to the development of vascular injury in acute KS. Although our present observations have been restricted to KS, the development of cytotoxic antibodies directed to monokine-inducible endothelial cell antigens may also be found in other vasculitides accompanied by immune activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for Activity
Gillis, S., Ferm, M. M., Ou, W., & Smith, K. A. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.6.2027 · Cited by 3,273
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V., Gillis, S., Henney, C. S., Kronheim, S. R., Grabstein, K., et al. (1985) · Nature · doi:10.1038/315641a0 · Cited by 1,579
Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
Nawroth, P. P., & Stern, D. M. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.3.740 · Cited by 1,311
Bevilacqua, M. P., Pober, J. S., Wheeler, M. E., Cotran, R. S., & Gimbrone, M. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112200 · Cited by 1,104
Self-citationBevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,067
Self-citationNucleotide sequence of human monocyte interleukin 1 precursor cDNA.
Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., & Dinarello, C. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7907 · Cited by 1,042
Gamble, J. R., Harlan, J. M., Klebanoff, S. J., & Vadas, M. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8667 · Cited by 1,033
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S., & Gimbrone, M. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.618 · Cited by 935
Self-citationHuman Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial Cultivation
Thornton, S. C., Mueller, S. N., & Levine, E. M. (1983) · Science · doi:10.1126/science.6635659 · Cited by 793
Pober, J. S., Bevilacqua, M. P., Mendrick, D. L., Lapierre, L. A., Fiers, W., & Gimbrone, M. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.5.1680 · Cited by 736
Self-citation
Cited by
Leung, D. M., Kurt-Jones, E., Newburger, J., Cotran, R., Burns, J., & Pober, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91910-7 · Cited by 381
Self-citationKawasaki disease: pathophysiology and insights from mouse models
Noval Rivas, M., & Arditi, M. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0426-0 · Cited by 310
Rife, E., & Gedalia, A. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00941-4 · Cited by 276
Platt, J. L., Vercellotti, G. M., Lindman, B. J., Oegema, T. R., Bach, F. H., & Dalmasso, A. P. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.4.1363 · Cited by 273
Ramaswamy, A., Brodsky, N. N., Sumida, T. S., Comi, M., Asashima, H., Hoehn, K. B., Li, N., Liu, Y., Shah, A., Ravindra, N. G., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.003 · Cited by 271
Matsubara, T., Furukawa, S., & Yabuta, K. (1990) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(90)90166-n · Cited by 256
Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin
Galvin, J. E., Hemric, M. E., Ward, K., & Cunningham, M. W. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7132 · Cited by 248
HASHIMOTO, H., IGARASHI, N., YACHIE, A., MIYAWAKI, T., HASHIMOTO, T., & SATO, T. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.31 · Cited by 21
Metadata
- Authors
- Leung, D. Y., Geha, R. S., Newburger, J. W., Burns, J. C., Fiers, W., Lapierre, L. A., & Pober, J. S.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1986-12-01
- Volume
- 164
- Issue
- 6
- Pages
- 1958-1972
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2131166082
- Cited by
- 278
- References
- 33
- FWCI
- 17.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.